Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications metabolically healthy obesity risk incident ischemic heart disease stroke ���
… results (e.g., scientific conferences, peer-reviewed publications ) …
… from Phase 1, Phase 2, and Phase 3 studies (peer-reviewed publications; congress abstracts, posters, and presentations; … data on file – at the discretion of the manufacturer Disease information Product information Version 4.1 (2020) … proposition) Section 2 Product Information and Disease Description Section 3 Clinical Evidence - studies …
… clinical trials in various areas, such as cardiovascular disease, rare diseases, cognitive disorders, oncology, chemoprevention, obesity, and health literacy. He has a background in the …
… International Journal of Clinical Oncology, PLoS One, Stroke, Population Health Management, Evaluation and Program … AcademyHealth Annual Research Meeting, International Stroke Conference, American Thoracic Society (ATS) …
… Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE); August 29, 2017. Montreal, Canada. … that the use of carbamazepine in pregnancy increases the risk for preterm delivery in comparison to no use of … they seem to indicate that there might be an increased risk for preterm delivery. Results for lamotrigine are not …
… intelligence (AI) and advanced spatial analytics in a risk-adjustment framework. Called RTI Rarity™, this database … predictive analytic methods to provide localized SDOH risk scores constructed with a health equity focus. It … those from the American Community Survey, Centers for Disease Control and Prevention, Opportunity Atlas, and …
… Devices (AEMPS), Spain Spanish Working Group on Chron’s Disease and Ulcerative Colitis (GETECCU), Spain University of … Netherlands Related Services Pharmacoepidemiology and Risk Management Real-World Evidence Staff Members Susana …
Drug Safety in Pregnancy Satisfy Regulatory Requirements With Help From Our Perinatal Pharmacoepidemiology Research Team The safety of medical products when used in pregnancy is often not well characterized at the time of marketing authorization unless …
… cost-benefit, cost-utility, and benefit-risk, as well as budget-impact modeling. Ms. McDade has … prostate cancer; chronic idiopathic constipation; Crohn's disease; and ulcerative colitis. Ms. McDade is an expert … HIV, COPD, asthma, hemophilia, prostate cancer, and stroke models. …
… confounding control by stratification of rate data, risk data and case-control data, study size and power …